Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Cash from Investing Activities (2020 - 2025)

Roivant Sciences (ROIV) has disclosed Cash from Investing Activities for 6 consecutive years, with $109.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities rose 103.85% year-over-year to $109.5 million, compared with a TTM value of -$3.7 billion through Dec 2025, down 293.92%, and an annual FY2025 reading of -$1.8 billion, down 133.94% over the prior year.
  • Cash from Investing Activities was $109.5 million for Q4 2025 at Roivant Sciences, down from $120.4 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $5.2 billion in Q4 2023 and bottomed at -$3.3 billion in Q3 2024.
  • Average Cash from Investing Activities over 5 years is -$101.2 million, with a median of -$2.3 million recorded in 2021.
  • The sharpest move saw Cash from Investing Activities skyrocketed 3392.76% in 2023, then plummeted 112409.43% in 2025.
  • Year by year, Cash from Investing Activities stood at $309.0 million in 2021, then tumbled by 151.08% to -$157.8 million in 2022, then surged by 3392.76% to $5.2 billion in 2023, then plummeted by 154.66% to -$2.8 billion in 2024, then surged by 103.85% to $109.5 million in 2025.
  • Business Quant data shows Cash from Investing Activities for ROIV at $109.5 million in Q4 2025, $120.4 million in Q3 2025, and -$1.1 billion in Q2 2025.